Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing

Allergy. 2021 Aug;76(8):2605-2607. doi: 10.1111/all.14839. Epub 2021 Apr 22.

Authors

Leonardo Bianchi¹, Filippo Biondi¹, Katharina Hansel¹, Nicola Murgia², Marta Tramontana¹, Luca Stingeni¹

Affiliations

¹ Department of Medicine and Surgery, Section of Dermatology, University of Perugia, Perugia, Italy.
² Department of Medicine and Surgery, Section of Occupational Medicine, Respiratory Diseases and Toxicology, University of Perugia, Perugia, Italy.

No abstract available

Keywords: SARS-CoV-2 vaccine; adverse drug reaction; intradermal test; skin test.

Publication types

Letter

MeSH terms

Angioedema* / chemically induced
Angioedema* / diagnosis
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Skin Tests

Substances

COVID-19 Vaccines